What is Endotoxin Testing?
In short
Endotoxin testing detects bacterial endotoxins — fragments of the outer membrane of Gram-negative bacteria — in pharmaceutical products, medical devices and water. Because endotoxins can cause fever and severe reactions even in tiny amounts, regulators require every parenteral product to be tested and to fall below a defined endotoxin limit.
Endotoxins are lipopolysaccharides (LPS) released when Gram-negative bacteria break down. They are heat-stable and are not removed by ordinary sterilisation, so a product can be sterile yet still contain dangerous endotoxin.
Testing quantifies the endotoxin present and compares it to the product's endotoxin limit, which is derived from the maximum dose a patient may receive. The three established approaches are the LAL test, recombinant Factor C (rFC), and the Monocyte Activation Test (MAT).
Why it matters
Even nanogram amounts of endotoxin can trigger a pyrogenic response. Reliable detection protects patients and is a release requirement for every injectable product.
Frequently asked
Why is endotoxin testing required?
What is the endotoxin limit?
More articles
Assay Development explained
How a test moves from feasibility through optimisation to a fully validated, robust assay.
GMP explained
The quality system that ensures every batch of a regulated product meets its specification.
How does Lateral Flow Testing work?
The capillary-driven technology behind rapid tests, explained step by step.
LAL vs recombinant Factor C (rFC)
The traditional horseshoe-crab test compared with the sustainable, animal-free synthetic alternative.
Sensitivity vs Specificity
The two measures that describe how trustworthy a diagnostic result really is.
What is an ELISA?
The plate-based immunoassay that quantifies proteins, antibodies and hormones with a colour change.